2024 Review-Breakthroughs that Redefined the Pharma Landscape Kumar Jeetendra | January 15, 2025 The year 2024 has been momentous for the pharmaceutical sector, characterized by new inventions, changes in policies, and partnerships that are likely to transform the future of health care. From new treatment methods to cutting edge technological development, here’s a summary of the main events that have transformed the pharm industry this year. Broader Use …
Pharma Horizons 2025 Kumar Jeetendra | February 7, 2025 The year 2025 is approaching, and the pharmaceutical sector is at a crossroads of change, facing clashing innovations from science, technology, and policy implementations. All of these changes are going to alter the landscape of drug development. So, which driving factors dictate this development and how will they impact medicine in the future? Let’s take …
The Evolution of Life Sciences: Ceratosaurus to CRISPR Kumar Jeetendra | April 8, 2025 Life sciences-an umbrella that today spans molecular biology, pharmacogenomics, biotechnology, and synthetic biology—had surprisingly humble beginnings. While life sciences begin with the discovery of ancient fossils like Ceratosaurus and culminate with the gene-editing prowess of CRISPR, they stand as a testament to the tenacity and ingenuity of humans. How Life Science Advanced from Fossil Hunting …
Sartorius completes acquisition of MatTek Kumar Jeetendra | July 2, 2025 The life science group Sartorius has successfully closed the acquisition of MatTek Corp, including Visikol Inc, from the Swedish BICO Group AB, as announced in April. The acquisition was completed on July 1, 2025, following the receipt of the required regulatory approval and the fulfillment of other customary closing conditions. With the integration of the …
Pharma 2030: AI, Automation & The Next Era of Drug Development Kumar Jeetendra | October 6, 2025 For the first time in its chronicle, the pharmaceutical industry is on the verge of crossing a transformative threshold. The next decade and a half will not focus on the completion of incremental improvements but on the determining of a new paradigm in the intricate relationship of science and technology. The paradigm will focus on …
